A Single Intravenous Dose Study of E3112 in Japanese Healthy Adult Male Subjects

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 25, 2017

Primary Completion Date

June 12, 2017

Study Completion Date

November 22, 2017

Conditions

Healthy Male Volunteers

Interventions

DRUG

Placebo

Intravenous infusion

DRUG

E3112

Intravenous infusion

Trial Locations (1)

EA Pharma Trial Site, Toshima City

All Listed Sponsors

lead

EA Pharma Co., Ltd.

INDUSTRY

NCT03014895 - A Single Intravenous Dose Study of E3112 in Japanese Healthy Adult Male Subjects | Biotech Hunter | Biotech Hunter